Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Edwin Singer, M.D.

Co-Author

This page shows the publications co-authored by Daniel Singer and Joshua Metlay.
Connection Strength

0.995
  1. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clin Microbiol Infect. 2002; 8 Suppl 2:1-11.
    View in: PubMed
    Score: 0.251
  2. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med. 1998 Sep 14; 158(16):1813-8.
    View in: PubMed
    Score: 0.200
  3. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med. 1998 Sep; 92(9):1137-42.
    View in: PubMed
    Score: 0.199
  4. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997 Jul; 12(7):423-30.
    View in: PubMed
    Score: 0.184
  5. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med. 2000 Jan 10; 160(1):98-104.
    View in: PubMed
    Score: 0.055
  6. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998 Jun 22; 158(12):1350-6.
    View in: PubMed
    Score: 0.049
  7. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997 Jul 14; 157(13):1453-9.
    View in: PubMed
    Score: 0.046
  8. Community-acquired pneumonia. N Engl J Med. 1996 Mar 28; 334(13):862; author reply 862-3.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.